Teacher Retirement System of Texas Grows Position in STERIS plc $STE

Teacher Retirement System of Texas lifted its stake in STERIS plc (NYSE:STE) by 85.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 23,957 shares of the medical equipment provider’s stock after buying an additional 11,070 shares during the quarter. Teacher Retirement System of Texas’ holdings in STERIS were worth $6,074,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of STERIS by 0.4% in the third quarter. Vanguard Group Inc. now owns 12,213,521 shares of the medical equipment provider’s stock worth $3,022,114,000 after buying an additional 50,393 shares in the last quarter. State Street Corp lifted its holdings in shares of STERIS by 4.0% in the third quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock worth $1,077,564,000 after buying an additional 166,736 shares in the last quarter. Orbis Allan Gray Ltd lifted its holdings in shares of STERIS by 36.0% in the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after buying an additional 556,088 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in shares of STERIS by 16.4% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock worth $387,797,000 after buying an additional 221,199 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of STERIS by 4.9% in the third quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider’s stock worth $316,758,000 after buying an additional 59,443 shares in the last quarter. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Analyst Upgrades and Downgrades

STE has been the topic of several research analyst reports. Wall Street Zen downgraded shares of STERIS from a “strong-buy” rating to a “buy” rating in a report on Sunday. Weiss Ratings downgraded shares of STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, April 16th. Five research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $275.20.

STERIS Price Performance

STERIS stock opened at $221.86 on Monday. The company has a market cap of $21.76 billion, a price-to-earnings ratio of 30.94 and a beta of 1.07. The firm’s fifty day moving average is $228.82 and its 200 day moving average is $245.35. The company has a quick ratio of 1.75, a current ratio of 2.48 and a debt-to-equity ratio of 0.26. STERIS plc has a 52-week low of $209.98 and a 52-week high of $269.44.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The company’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Sell-side analysts forecast that STERIS plc will post 10.22 EPS for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 19th. Investors of record on Tuesday, February 17th were paid a dividend of $0.63 per share. The ex-dividend date of this dividend was Tuesday, February 17th. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. STERIS’s dividend payout ratio is presently 35.15%.

Insider Transactions at STERIS

In related news, Director Cynthia L. Feldmann sold 3,098 shares of the company’s stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $237.21, for a total transaction of $734,876.58. Following the sale, the director owned 705 shares of the company’s stock, valued at $167,233.05. This represents a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.07% of the stock is currently owned by insiders.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.